RECRUITING

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, depression, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.

Official Title

Implementation of an At-Home Multimodal Integrative Therapy Via Virtual Reality for Patients With Cancer-Treatment Associated Symptoms

Quick Facts

Study Start:2024-12-04
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06248216

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 88 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults ages 18-88
  2. * Cancer diagnosis (histology verified)
  3. * Had surgical intervention, completed chemotherapy or radiation for therapeutic purposes
  4. * Documented symptoms of cancer or cancer therapy including at least one of the following: pain, anxiety, sleep difficulty, fatigue, neuropathy
  5. * English speaker (written and spoken)
  1. * Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years
  2. * Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
  3. * Diagnosis and treatment of chronic pain, neuropathy, fatigue, sleep or anxiety disorder prior to cancer diagnosis
  4. * Current Hospice or palliative care only recipients
  5. * Color-blindness
  6. * Impaired or uncorrected hearing
  7. * Lifetime alcohol/drug dependence or alcohol/drug abuse in past 3 months
  8. * Conditions that would interfere with the VR mask placement (e.g. trauma, burn, infection)
  9. * Known history of severe motion sickness
  10. * Pregnancy or breast feeding

Contacts and Locations

Study Contact

Katia Matychak, MS
CONTACT
410-706-5975
katiamatychak@umaryland.edu

Study Locations (Sites)

Luana Colloca
Baltimore, Maryland, 21201-1512
United States
University of Maryland
Baltimore, Maryland, 21201-1512
United States

Collaborators and Investigators

Sponsor: University of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-04
Study Completion Date2026-08

Study Record Updates

Study Start Date2024-12-04
Study Completion Date2026-08

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Cancer Pain
  • Virtual Reality